Barclays PLC Zai Lab LTD Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Zai Lab LTD stock. As of the latest transaction made, Barclays PLC holds 3,702 shares of ZLAB stock, worth $134,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,702

Previous 846 337.59%

Holding current value

$134,826

Previous $20,000 385.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$24.61 - $33.18 $70,286 - $94,762	2,856 Added 337.59%	3,702 $97,000
Q3 2024 Nov 15, 2024	SELL	$16.25 - $24.14 $67,795 - $100,712	-4,172 Reduced 83.14%	846 $20,000
Q2 2024 Aug 14, 2024	SELL	$13.72 - $21.55 $360,396 - $566,075	-26,268 Reduced 83.96%	5,018 $87,000
Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $489,441 - $822,384	30,686 Added 5114.33%	31,286 $502,000
Q2 2023 Aug 03, 2023	SELL	$25.3 - $39.67 $1.82 Million - $2.85 Million	-71,947 Reduced 99.17%	600 $17,000
Q1 2023 May 04, 2023	BUY	$30.21 - $48.1 $548,220 - $872,870	18,147 Added 33.36%	72,547 $2.41 Million
Q4 2022 Feb 13, 2023	SELL	$22.28 - $38.71 $2.09 Million - $3.62 Million	-93,632 Reduced 63.25%	54,400 $1.67 Million
Q3 2022 Nov 03, 2022	SELL	$34.2 - $51.69 $3.91 Million - $5.91 Million	-114,384 Reduced 43.59%	148,032 $5.06 Million
Q2 2022 Aug 12, 2022	BUY	$23.14 - $49.68 $2.96 Million - $6.36 Million	127,930 Added 95.13%	262,416 $9.1 Million
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $3.73 Million - $8.66 Million	134,486 New	134,486 $5.91 Million
Q3 2020 Nov 12, 2020	SELL	$73.3 - $89.48 $1.55 Million - $1.89 Million	-21,129 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$48.82 - $82.53 $636,075 - $1.08 Million	13,029 Added 160.85%	21,129 $1.74 Million
Q1 2020 May 13, 2020	BUY	$39.1 - $62.9 $180,055 - $289,654	4,605 Added 131.76%	8,100 $417,000
Q4 2019 Feb 10, 2020	SELL	$29.79 - $43.06 $16,563 - $23,941	-556 Reduced 13.73%	3,495 $145,000
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $102,744 - $126,955	3,372 Added 496.61%	4,051 $131,000
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $17,470 - $24,301	679 New	679 $23,000
Q1 2019 May 15, 2019	SELL	$21.71 - $31.54 $60,570 - $87,996	-2,790 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.95 - $24.72 $41,710 - $68,968	2,790 New	2,790 $65,000

Others Institutions Holding ZLAB

# of Institutions

146

Shares Held

53M

Call Options Held

103K

Put Options Held

439K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account